Praxis Precision Medicines Inc (PRAX)
54.81
+0.27
(+0.50%)
USD |
NASDAQ |
May 06, 11:11
Praxis Precision Medicines 1 Year Total Returns (Daily): 249.6% for May 3, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| May 03, 2024 | 249.6% |
| May 02, 2024 | 250.6% |
| May 01, 2024 | 228.3% |
| April 30, 2024 | 251.7% |
| April 29, 2024 | 264.5% |
| April 26, 2024 | 254.7% |
| April 25, 2024 | 239.0% |
| April 24, 2024 | 221.6% |
| April 23, 2024 | 204.3% |
| April 22, 2024 | 197.7% |
| April 19, 2024 | 186.8% |
| April 18, 2024 | 193.0% |
| April 17, 2024 | 219.4% |
| April 16, 2024 | 249.4% |
| April 15, 2024 | 255.9% |
| April 12, 2024 | 310.9% |
| April 11, 2024 | 282.4% |
| April 10, 2024 | 289.7% |
| April 09, 2024 | 303.9% |
| April 08, 2024 | 311.4% |
| April 05, 2024 | 278.1% |
| April 04, 2024 | 306.9% |
| April 03, 2024 | 315.4% |
| April 02, 2024 | 357.9% |
| April 01, 2024 | 382.9% |
| Date | Value |
|---|---|
| March 28, 2024 | 377.7% |
| March 27, 2024 | 338.5% |
| March 26, 2024 | 407.3% |
| March 25, 2024 | 312.0% |
| March 22, 2024 | 274.1% |
| March 21, 2024 | 232.8% |
| March 20, 2024 | 258.2% |
| March 19, 2024 | 247.9% |
| March 18, 2024 | 253.2% |
| March 15, 2024 | 222.5% |
| March 14, 2024 | 212.7% |
| March 13, 2024 | 234.5% |
| March 12, 2024 | 242.9% |
| March 11, 2024 | 233.8% |
| March 08, 2024 | 258.9% |
| March 07, 2024 | 268.6% |
| March 06, 2024 | 249.3% |
| March 05, 2024 | 259.1% |
| March 04, 2024 | 266.0% |
| March 01, 2024 | 9.00% |
| February 29, 2024 | 1.75% |
| February 28, 2024 | 3.80% |
| February 27, 2024 | -3.95% |
| February 26, 2024 | -5.17% |
| February 23, 2024 | -19.07% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-92.94%
Minimum
Mar 24 2023
407.3%
Maximum
Mar 26 2024
-43.12%
Average
-67.99%
Median
1 Year Total Returns (Daily) Benchmarks
| Catalyst Pharmaceuticals Inc | -11.33% |
| Regeneron Pharmaceuticals Inc | 19.15% |
| Atossa Therapeutics Inc | 150.6% |
| ADMA Biologics Inc | 95.69% |
| Viking Therapeutics Inc | 258.8% |